#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Andersen-Tawil syndrome Gastroenteropancreatic neuroendocrine tumour disease Non-renal cell carcinoma of kidney Subdural haematoma Bronchiectasis Bronchopulmonary dysplasia Stevens-Johnson syndrome Erdheim-Chester disease Glomerulonephritis Hyperchylomicronaemia Exudative retinopathy Mycobacterium abscessus infection Myelodysplastic syndrome Gastrooesophageal cancer Pulmonary fibrosis More trials…

    Learn about Rare Diseases

    Soft tissue sarcoma – Diagnostics Myxofibrosarcoma – Treatment Hairy cell leukaemia – Treatment Isodicentric chromosome 15 syndrome – Trials in Disease Behcet’s syndrome – Trials in Disease Cerebral arteriovenous malformation haemorrhagic – Diagnostics Systemic mastocytosis – Life with Disease Richter’s syndrome – Trials in Disease Hereditary ataxia – Treatment Retinitis pigmentosa – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ETX-19477 Sebetralstat Retinol Acetate Efavirenz Lisocabtagene Maraleucel Kpl-404 Cefiderocol Mk-1088 Nipocalimab Mbf-015 SAR445399 Rupatadine Teicoplanin Nebivolol Amcenestrant Felis Domesticus (555) Opium, Standardized Powdered Erlotinib Ethinylestradiol Ima203Cd8 More therapies…

    Learn about Your Condition

    Vulvovaginal dryness Arteriovenous graft thrombosis Androgenetic alopecia Hepatocellular carcinoma Carpal tunnel syndrome Mechanical ventilation Obsessive-compulsive disorder Endometrial cancer metastatic Primary hyperoxaluria Neuroblastoma recurrent Angiopathy Labour induction Muscle injury Arthralgia Adenovirus infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effects of Rifampicin, Amoxicillin, and Moxifloxacin in Treating Prosthetic Joint Infections Caused by Cutibacterium acnes for Affected Patients

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Medical device site joint infection
    Investigated Drugs:
    • Moxifloxacin
    • Amoxicillin
    • Clindamycin
    France

  • Study on Metformin for Prolonging Pregnancy in Women with Preterm Preeclampsia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pre-eclampsia
    Investigated Drugs:
    • Metformin Hydrochloride
    Finland Norway Sweden

  • Study on Continuing Somatostatin Analogues with Sunitinib, Octreotide, and Lutetium (177Lu) Oxodotreotide for Patients with Neuroendocrine Tumors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neuroendocrine tumour
    • Gastroenteropancreatic neuroendocrine tumour disease
    • Pancreatic neuroendocrine tumour
    Investigated Drugs:
    • Lutetium (177Lu) Oxodotreotide
    • Everolimus
    • Lanreotide
    Belgium The Netherlands

  • Study on Minocycline and Celecoxib for Patients with Major Depressive Disorder Not Responding to Antidepressants

    Recruiting

    3 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Minocycline
    • Celecoxib
    Belgium

  • Study on the Effects and Safety of Nicotinamide for Patients with Type 2 Diabetes and Liver Fibrosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatic fibrosis
    Investigated Drugs:
    • Nicotinamide
    Spain

  • Study on Fremanezumab for Pain Relief in Patients with Complex Regional Pain Syndrome

    Recruiting

    2 1 1
    Investigated Diseases:
    • Complex regional pain syndrome
    Investigated Drugs:
    • Fremanezumab
    Denmark
Previous Page
1 … 588 589 590 591 592 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!